Raspberry Lift Healthy Body Fruit Notes feature a balanced blend of cannabinoids designed to increase mental clarity and encourage positive eating habits.

InMed Pharmaceuticals Inc. has launched B2B sales of delta-9-dominant tetrahydrocannabivarin (THCV) into the health and wellness sector via its wholly-owned subsidiary, BayMedica LLC.

In the first half of 2022, Radicle Science will continue to conduct rigorous clinical trials on CBD products while also commencing on blinded, randomized, placebo-controlled clinical trials on rare cannabinoids.

Cheeba Chews has launched THCV-Charged Energy Chews, the latest addition to the company’s Wellness Line.

Keef Brands has unveiled purpose-driven beverages with minor cannabinoids designed to offer functional effects, including stimulation, relaxation, and sleep.

CannaCraft has launched its new brand Gem + Jane, a women-focused sparkling botanical beverage that blends simple ingredients with microdoses of cannabinoids.

Cannabis Global, Inc. says it has successfully applied production techniques developed for tetrahydrocannabivarin (THC-V) to cannabinol (CBN), another rare cannabinoid the company believes has growth potential as a new cannabinoid-based products market.

Pending full release of the products, the company has implemented a 30-day beta testing period, during which production for general release will continue.

Cannabis Global, Inc., is  implementing a program to produce commercially viable quantities of tetrahydrocannabivarin (THC-V) for use in its own products to be released later this month.

Cannabis Global, Inc.’s Project Varin research program has yielded a new tetrahydrocannabivarin (THC-V) delivery system providing for sustained release of the cannabinoid over a predetermined period of time and two other delivery systems for immediate release.